# Ologen (OculusGen)-Glaucoma MMC Control Trial in India

> **NCT00449098** · PHASE4 · UNKNOWN · sponsor: **Pro Top & Mediking Company Limited** · enrollment: 40 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** OculusGen Biodegradable Collagen Matrix Implant
- **DRUG:** Trabeculectomy with MMC

## Key facts

- **NCT ID:** NCT00449098
- **Lead sponsor:** Pro Top & Mediking Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449098, "Ologen (OculusGen)-Glaucoma MMC Control Trial in India". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00449098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*